Long-term unsupervised mobility assessment in movement disorders - 23/04/20
, Arash Atrsaei, MSc f, Yuhan Zhou, MSc g, Anat Mirelman, ProfPhD c, d, Kamiar Aminian, ProfPhD f, Alberto J Espay, ProfMD i, Clint Hansen, PhD a, Luc J W Evers, BSc h, Andreas Keller, ProfPhD j, k, Claudine Lamoth, PhD g, Andrea Pilotto, MD l, m, Lynn Rochester, ProfPhD n, o, Gerhard Schmidt, ProfPhD b, Bastiaan R Bloem, ProfPhD h, Walter Maetzler, ProfMD aSummary |
Mobile health technologies (wearable, portable, body-fixed sensors, or domestic-integrated devices) that quantify mobility in unsupervised, daily living environments are emerging as complementary clinical assessments. Data collected in these ecologically valid, patient-relevant settings can overcome limitations of conventional clinical assessments, as they capture fluctuating and rare events. These data could support clinical decision making and could also serve as outcomes in clinical trials. However, studies that directly compared assessments made in unsupervised and supervised (eg, in the laboratory or hospital) settings point to large disparities, even in the same parameters of mobility. These differences appear to be affected by psychological, physiological, cognitive, environmental, and technical factors, and by the types of mobilities and diagnoses assessed. To facilitate the successful adaptation of the unsupervised assessment of mobility into clinical practice and clinical trials, clinicians and researchers should consider these disparities and the multiple factors that contribute to them.
Le texte complet de cet article est disponible en PDF.Plan
Vol 19 - N° 5
P. 462-470 - mai 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
